RE: Results12 Jun 2021 16:41
vascular, I’ve just listened to the Investor Meet interview again. My take on the China £30/£50 millions was that is for Orphan to train the Chinese to do a study themselves. He went on to say this wouldn't be a problem as only the Chinese pharmas would want to use a Chinese study. The rest of the western world would use OOrphan